The mm Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mm Hub cannot guarantee the accuracy of translated content. The mm and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Multiple Myeloma Hub is an independent medical education platform, sponsored by Bristol Myers Squibb, GSK, Johnson & Johnson, Pfizer, Roche and Sanofi. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mm content recommended for you
What factors correlate with a better response to BCMA-directed CAR T-cell products?
Featured:
Nina ShahDuring the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the Multiple Myeloma Hub was pleased to speak to Nina Shah, UCSF, San Francisco, US. We asked, What factors correlate with a better response to BCMA-directed CAR T-cell products?
What factors correlate with a better response to BCMA-directed CAR T-cell products?
In this video, Shah discusses how data from the KarMMa trial can be used to try to establish a correlation between clinical and drug product characteristics, and patients achieving a complete response. Shah then talks about the importance of determining what patients are more likely to achieve a complete response, so CAR T-cell therapy can be given appropriately to patients.